Abstract The aim of this study was to evaluate the effectiveness of the membrane biosynthesis gene disruption in MRSA (methicillin resistant Staphylococcus aureus) using sea cucumber extract (SBE). The disruption of membrane biosynthesis gene also known as multiple peptide resistance gene (mprF), would impair the lysylation of cell membrane phosphatiglycerol and thus reduce antibiotic resistance in MRSA. The membrane permeability assay was done to determine the degree of homology of the SBE treated RNA and the resulting translated protein in MRSA. Bacterial cell permeabilization test was performed to confirm the permeabilization effect of SBE on bacterial cell membranes of the MRSA treatments. The effectiveness of SBE on mprF gene disruption was further confirmed using fluorescence microscopy, modified disc diffusion assay, minimal inhibitory concentration and checkerboard method. Up to 35 % of nucleotide changes at RNA level were detected in methicillin-susceptible S. aureus (MSSA) isolates and less than 10 % in MRSA isolates when treated with SBE, each resulted in alterations in the post-translation protein sequence. The fluorescence assay showed the uptake of fluorescence dye by the bacteria cells treated with SBE, indicating rupturing of the bacterial cell MSSA and MRSA membrane barriers. The in-combination treatments between SBE and classical antibiotics against MRSA resulted in improved inhibitory activities. This study illustrated that the use of SBE caused mprF gene disruption to increase MRSA susceptibility towards AMP substances and classical antibiotics. Thus, disruption of mprF gene can be potential means for reducing antibiotic resistant in MRSA.
Introduction
Staphylococcus aureus has become the most difficult Gram-positive bacterium to handle, as it is highly prevalent and resistant against virtually every antibiotic deployed [1] [2] [3] including antimicrobial of the host components. The resistance is mediated through mobile genetic elements found in all methicillin-resistant S. aureus (MRSA) strains located in staphylococcal cassette chromosome mec (SCCmec). Developments of resistance in S. aureus involved a variety of mechanisms by expansion of resistant genes such as blaZ, mecA, parC, gyrA, gyrB, sulA, drfB, ermA, ermB, ermC, vat, vatB and the list increased parallel to antibiotics treatments over time [4] . It is clear that traditional antibiotics act by inhibiting bacterial functions that are essential for logarithmic growth. However these antibiotics may impose selective pressure that fosters the growth of antibiotic-resistant strains [5] . Therefore, new MRSA inhibitors with capacities to decrease bacterial virulence, disturb the resistance ability or disrupt the interaction pathways between the hosts and the pathogens are needed [6] . The efforts to target the virulent and resistant factor sites in S. aureus may enforce weaker selective pressure for development of antibiotic resistance to current antibiotics.
There are three main drug target sites in bacteria: the cell wall biosynthesis, bacterial protein synthesis and bacterial DNA replication and repair. The best target would be disrupting cell wall biosynthesis, as this target confirms penetration of antibacterial agents deep inside the cell for further reactions to disturb protein biosynthesis, DNA replication and repair [7] . The multiple peptide resistant factor (mprF) gene is responsible for intact cell membranes in S. aureus. It facilitates phosphatidyglycerol (PG) lysylation and modifies the net charge of PG from negative to positive, hence it impairs the interaction of cationic peptides from the host onto the bacterial membranes [8] . The modification of the PG net charge in S. aureus surfaces makes it more resistant to cationic antibiotics and natural antimicrobial peptides, usually in positive charges. MprF genes are proven to be resistance determinants for host defence peptides, affect the resistance to b-lactam antibiotics and affect vancomycin and daptomycin susceptibility in S. aureus [9, 10] . Using this gene as an antibiotic target candidate would interrupt the net charge changes and promote susceptibility of S. aureus to naturally occurring antimicrobial peptide (AMP) in host and classical antibiotics.
Considering these factors, AMP derived from first line defence of the innate immunity which has positive charge with 20 to 40 amino acid length would be the best candidates against S. aureus. The search continues to screen for alternative AMP from sea cucumbers which are benthic marine invertebrates normally found in the bottom substrates rich in microorganism. The close interaction between the microorganisms and sea cucumber may produce beneficial AMP. The sea cucumber is widely used in traditional medicine in South-east Asian for the treatment of wound and skin infections. The chemical compounds of sea cucumber are increasingly described and have been isolated as new resources for development of medicinal products [11] . In Malaysia, research on bioactive molecules derived from sea cucumbers focus on antiproliferative, antioxidant and antimicrobial activities [12] . The search leads to more discoveries of AMPs from different marine invertebrates; for instance, clavaspirin derived from tunicates was found to permeabilize the outer and inner membranes of Escherichia coli. The mechanism involves manipulating the net charge of pathogens, lipopolysaccharides, lipoteichoic acid and bacteria phospholipids, which are influenced by pH [13] . An AMP known as Styelin D, also found in tunicates, inhibited Gram-positive and Gram-negative bacteria, and was effective in high salinity conditions [14] . The AMPs produced by marine invertebrates are probably from their innate immunity system as they have survived for million years without any adaptive immune system.
From this background, this study was conducted to validate mprF gene as antibiotic target gene using AMP from sea cucumber crude extract (SBE) as MRSA inhibitor. The study was designed to evaluate the mprF gene, which is responsible for building up intact membrane structure in S. aureus, as a target site to reduce its antibiotic resistance. The study used molecular biotechnology combined with fluorescence assays for assessing membrane disruption and its permeability to classical antibiotics incombination with SBE.
Materials and Methods

Antimicrobial Agents and Reagents
Vancomycin and penicillin antibiotic discs, ampicillin, fusidic acid, penicillin, polymyxin B, and methicillin powder, and SYTOX Green dye were all purchased from Becton-Dickinson, France.
Super Critical Fluid Extraction (SFE) with Liquid Carbon Dioxide
The antimicrobial crude extracted from Stichopus badionotus Selenka, 1867, a sea cucumber collected from West Coast Peninsular Malaysia was produced using a laboratory scale SFE system (Thar Model 500, Thar Technologies Inc., Pittsburg, PA, USA). Briefly, 100 g of S. badionotus (freeze dried powder) was inserted into thermal-controlled extraction vessel. The vessel pressure was 300 bars, with 40°C; and this setting was maintained by a control unit. After the desired pressure and temperature were reached, the levels were kept constant for 30 min. Then liquefied CO 2 was allowed to flow (flow rate of 20 g/min) continuously through the sample for 3 h. The extract was finally separated from the CO 2 phase and collected in a collector at ambient temperature and atmospheric pressure. The light brown SBE paste was stored in sample bottles and maintained at 4°C until used.
Spectrometric Analysis of Stichopus badionotus Extracts (SBE)
The crude of SBE was subjected to antimicrobial assays and characterized using gas chromatography mass spectrometry (GCMS). GCMS analysis of the Stichopus badionotus extract (SBE) was done using Shimadzu GCMS-QP2010 Plus equipped with BPX-5 column (30 m 9 0.25 mm 9 0.25 lm) and helium as gas carrier. The components of SBE were identified by comparison of the mass spectra with NIST21 library information.
Bacterial Strains and Media
Staphylococcus aureus isolates used in this study comprised American Type Culture Collection (ATCC) and laboratory strains of different sources: ATCC 700698, ATCC 29247, str9 and N8. The laboratory strains procured from Malaysian hospitals were maintained in the Microbiology Laboratory, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. All of the bacterial strains were preserved in trypticase soy broth (TSB) medium (Difco Laboratories, Detroit) containing 20 % (vol/vol) glycerol and stored at -80°C.
Molecular Membrane Permeabilization Assay
The experiments were conducted in 25 ml Erlenmeyer flask containing 10 ml of fresh TSB medium. Serial dilution of SBE was done in the flask and inoculated with an overnight culture of MSSA and MRSA, each with 100 ll of 10 7 cells ml -1 [15] . The suspension, 100 ll each was streaked on Mueller-Hinton Agar (MHA) and incubated at 37°C for 24 h. The colonies that grew on MHA were picked and subjected to molecular screening by PCR amplification of target genes. RNA of S. aureus treated with SBE was extracted using Master Pure TM Complete RNA Purification Kit (All Eights, Singapore). As soon as RNA yield and purity were confirmed, the RNA was converted to cDNA using Monster Script TM cDNA kit (All Eights, Singapore) based on the manufacturer's protocol. This process proceeded with PCR in which a reaction mixture in a volume of 25 ll containing PCR buffer (Fermentas, Canada), 1.8 mM MgCl 2 , 200 lM dNTPs, 20 pmol of forward and reverse primer, and 1 U taq polymerase (Fermentas, Canada) were used. The PCR program used was as follows: initial denaturation at 94°C for 5 s, annealing temperature, 55°C for 1 min, extension at 72°C for 2 min and a final extension at 72°C for 2 min. Primers for RT-PCR were designed manually based on gene regions of interest encoding for lysylation of phosphatidyglycerol in S. aureus membrane. The target gene sequences were obtained from the MRSA public domain database accession number HM140977. PCR amplification was performed using the following primer pair: mprF Forward (5 0 -GTATCGGGAGTTATCTGG-3 0 ) and mprF Reverse (5 0 -TCAACCTACGTGCTCTAC-3 0 ). The RT-PCR products were subjected to electrophoresis on 1.2 % agarose gels, stained with 0.2 lg ml -1 ethidium bromide, and viewed under UV light using the AlphaImager TM 2200 (Alpha Innotech, USA). The bands of interest were purified using the Qiagen PCR purification Kit (Qiagen, Germany) and sent for commercial sequencing (Medigene, Malaysia). The sequences were subjected to alignment analysis using Biologyworkbench 3.2 (http://workbench.sdsc.edu) to calculate percentages of similarity and to determine nucleotide changes. The obtained nucleotide sequences of treated and untreated S. aureus were then translated to protein using the software Expasy Translate Tool (http://us.expasy. org/tools/dna.html) and analyzed using protein BLAST in NCBI to determine the degree of homology of the translated protein compared to the same original protein in S. aureus. Protein similarities between the treated, untreated and original protein sequence from the protein database were then analyzed by alignment of the protein sequences using Biologyworkbench 3.2.
Bacterial Cell Permeabilization Test
This test was performed in order to confirm the permeabilization effect of SBE on bacterial cell membranes and compared to antibiotics with different modes of action [16] . MICs of antimicrobial agents (SBE, fusidic acid and polymyxin B) were determined prior to this experiment using the standard method of micro broth dilution as previously described by Clinical Laboratory Standard Institute (CLSI), performed in sterile 0.9 % NaCl solution containing 5 % TSB. Bacterial cells of MRSA and MSSA (100 ll of 10 7 cells ml -1 ), antibiotics for MSSA (MIC for polymyxin B 0.2 mg ml -1 , fusidic acid 0.2 mg ml -1 ), antibiotics for MRSA (MIC for polymyxin B 0.5 mg ml -1 , fusidic acid 0.5 mg ml -1 ), SBE for MSSA (3.75 mg/ml), SBE for MRSA (7.5 mg/ml) and SYTOX Green dye (5 lM) were combined and dispensed into black microplates at 100 ll/well. In other sets of treatments, only the values of antibacterial agents were changed to of the MIC, 19 MIC, and 29 MIC. The plates for all treatments were incubated for 6 h at 37°C, and the fluorescence intensities were measured with a fluorescence multiwell plate reader (SpectraMAX, Gemini XS).
Fluorescence Microscopy
The bacterial cells were treated with antibiotics or SBE at MIC, and then stained with SYTOX Green dye; they were observed under a fluorescence microscope (Leica, Germany). A green fluorescence filter was used to determine the fluorescence emitted by the stained bacterial cells. Photographs of cells with fluorescence spots were captured for evidence of dye penetration due to membrane disruption. For both experiments described in the bacterial cell permeabilization test and fluorescence microscope, positive controls used were antibiotics that target the membrane (polymyxin B), whereas negative controls were antibiotics that do not disrupt the membrane (fusidic acid).
Modified Disc Diffusion Assay
Synergism assays for in-combination relation between SBE and antibiotics were evaluated on MRSA and MSSA isolates using modified disc diffusion method [17] . Media of Mueller-Hinton Agar (MHA) (Merck, Germany) were prepared according to the manufacturer's protocol. The molten agar was autoclaved at 121°C for 15 min, and at 55°C the molten agar was poured into the plates. Aliquots of SBE were pipetted into the molten agar in plates to obtain the concentrations of 2.0, 4.0 and 6.0 mg/ml and left to cool. The solid agar then was lawn with isolates of MSSA and MRSA accordingly in the volume of 100 ll at 0.5 McFarland for each plate. Five antibiotics were placed on the lawn agar plates: ampicillin, 10 lg; vancomycin, 30 lg; methicillin, 10 lg; gentamicin, 10 lg; oxacillin, 10 lg and penicillin, 10 lg (Becton-Dickinson, France) and incubated for 24 h at 37°C. The diameter of each clear zone was recorded after incubation and experiment was done in triplicates [18] .
Minimal Inhibitory Concentration (MIC)
The MIC of antibacterial agent against test pathogen was determined by broth dilution method in accordance to CLSI methodology. Serial dilutions of antibacterial agents were made in Mueller-Hinton broth (MHB) with range of 0.1-10 mg/ml. Each tube was inoculated with 100 ll of 0.5 McFarland inoculums of test pathogens and mixed. A 100 ll of the suspension was spread on MHA and incubated at 37°C for 16 h. The MIC values of the antibacterial agents were defined as the lowest concentration that inhibited 80 % of visible bacterial growth.
Checkerboard Method
In-combination of antibacterial agents through checkerboard method was done to screen for potential relationships between the different antimicrobial agents determined by fractional inhibitory concentration (FIC) index [19] . Four clinical isolates (N8, 20, str5, and str9) and two reference strains from American type culture collection, ATCC 29247 for MSSA and ATCC 700698 for MRSA, were selected for checkerboard determination of in vitro interaction. Broth microdilution assays were performed at concentrations ranging from 1/32 to 2 times the MIC of SBE, and from 1/128 to 4 times the MIC of ampicillin and penicillin (Becton-Dickinson, France). The dilutions were made in 96-well plates in a checkerboard fashion, and the inoculum was prepared as aforementioned. The plates were incubated at 37°C for 24 h. For evaluation of interaction between two agents, calculations were done according to the formula listed below: 
Results and Discussion
Characterization of SBE via GCMS and Identification of Bio-Active Compounds
This paper describes the ability of anti-MRSA crude extracted from S. badionotus (SBE), molecular evaluation of the compound targeted genes, fluorescence confirmatory antibacterial mechanism assays and validation targeted sites with antibiotic assays. GC separation yielded 21 peaks identified via mass spectra with NIST21 library information and only three compounds exhibited potential against bacterial call wall particularly against MRSA (Fig. 1) . SBE substance composition analysis by mass spectrometry indicated a structure with molecular weight of 233. The fragmentation pattern suggested the presence of fluorine and benzene predicted to be anti-MRSA composition in a crude extract designated as SBE. The combination of fluorine and benzene known as benzeneethanamine, N-TFA-4 hydroxy, is a compound which characterizes the quinolone group compound (Fig. 1) . This antibacterial substance contained halogen groups, like fluorine are very useful to modulate the electronic effects on phenyl rings of drugs and important for penetration into bacterial cell [20] . Mass spectrometry also detailed the other composition of SBE with structures in the positions found to be similar to compound groups with antimicrobial potential; the 1,4-benzenediol,2-methoxy and 1,2,3-benzenetriol. All three substances in SBE may have demonstrated specific activities against Gram-positive S. aureus including the MRSA isolates independently or symbiotically. In this way it differs from other antibiotics produced by a tunicate, the Styela clava which produces styelin and clavanin, that are active against both Gram-positive and Gram-negative bacteria [14] . The synergism activities between substances extracted from natural organisms may contribute to antimicrobial ability but the mechanisms of action are complicated to predict [21] .
Molecular Confirmatory Assay
The antibiotic susceptibility of MRSA and MSSA isolates were assessed in the presence of multiple peptide resistance factor (mprF) gene, which is responsible for mediating biosynthesis of lysylphosphatiglycerol (L-PG) or L-lysine transfer to phosphatiglycerol (PG) layer [22] . The initial steps taken to increase virulence and resistance in S. aureus against membrane-damaging cationic antimicrobial molecules (CAMs) produced by host first line immune system, involved a mechanism to modify the anionic PG membrane with positively charged L-lysine. In this manner, S. aureus resistance to AMP and classical antibiotics depends on mprF gene, which is suitably chosen to be antibiotics target. Therefore, disrupting mprF gene or interrupting lysine transport to PG and maintaining the negative charges for PG will make it vulnerable to CAMs and classical antibiotics.
A molecular confirmatory assay resulted in successful mprF gene amplification by reverse-trancriptase PCR (RT-PCR), indicated by band positioned at corresponding size of 1241 bp in all SBE treated and untreated isolates (Fig. 2) . The expected single band was amplified using cDNA from the samples as template; whereas no amplification was produced from the PCR using non-reverse transcriptase control as template which acted as a negative control. This confirms that the cDNA used was specific and free from DNA contamination. Upon gene sequence alignment, several mutations which include changes, deletions or insertions of nucleotides were noted using the ClustalW Biology Workbench program. The nucleotide changes or mutations detected in the mprF gene were probably correlated with the effect of SBE, and predicted to be due to inhibitory activity of the AMP in SBE. The nucleotide changes in the SBE-treated MSSA mprF gene sequences for N8 and ATCC 29247 were 34.45 and 35 %, respectively from 1241 bp. For SBE-treated MRSA, the changes were 6.80 and 0.72 % in str9 and ATCC 700698, respectively. To improve understanding of the nucleotide changes based on SBE effect on S. aureus isolates, the sequences were further analyzed at the protein level through conceptual translation. Protein alignment showed base changes of 46.6 % in N8, 43.39 % in str9, 17.52 % in ATCC 29247, and no changes in protein sequence for ATCC 700698. The ATCC 700698 end product with no change in protein bases was 63 % homologous to the LPG synthase protein with accession number ADJ67256 (supplement 1). Protein homology of the isolates N8, str9, and ATCC 29247 to the translated LPG synthase protein was zero percent. The mutants with non-homology or protein function deletion of mprF gene were particularly susceptible to CAMPs. This made mutant strains become infected and non-virulent when tested in mouse model of infection [23] . Molecular assay subsequently revealed the potential target gene in MRSA and MSSA. Analysis based on selected gene from the GenBank database encoding for proteins related to membrane development in S. aureus, namely mprF gene showed that the designed primers were able to specifically amplify the above mentioned gene from all isolates in this study. The translated protein sequences obtained showed severe changes indicating loss of the mprF gene function as a lysine transporter. The lysine transporter is responsible for building the intact L-PG layer in S. aureus membranes with antibiotic resistant capabilities [22] . The protein sequences obtained from translated cDNA of the treated bacteria showed massive changes upon alignment, signifying a major change in function after being treated with the SBE compound. This was proven by the zero homology shared with the LPG synthase protein, as shown by the Blast protein analysis. Studies have shown that mprF gene products are L-PG synthase activity through assays of membrane fraction and in vitro L-PG synthase activity [24] . The inactivation of mprF gene from this study demonstrated that no modification of PG with Llysine led to reduced negative charge of bacteria membrane surface and this increased binding of AMPs by the bacteria. The mutant mprF studies have shown negative charge membranes attract cationic AMPs to the cytoplasmic membrane surface and decrease the MIC. The gene was detected in several pathogens including Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Enterococcus faecalis [25] .
Bacterial Cell Permeabilization Test
The penetrations of MRSA and MSSA cells treated with SBE at MIC dosages were indicated by the increasing intensities of the SYTOX Green dye (supplement 2). SY-TOX green is an organic compound that fluoresces upon interaction with nucleic acid. When the SBE disrupts membrane integrity of MRSA and MSSA isolates, the dye enters the cell and easily colours the nucleic acid (Fig. 3) . Increments in fluorescence intensities were also observed in the positive control with antibiotic polymyxin B, an antibiotic known to damage the pathogen membranes. The fluorescence intensities increased drastically in the first 60 min after treatment, indicating that the membrane integrity was affected and that the dye coloured the nucleic acid. The negative control antibiotic fusidic acid, known as a protein synthesis inhibitor, did not affect the bacterial cell membrane integrity and thus showed constant and low fluorescence intensities even after 4 h of incubation with the antibiotic. The results of this experiment agreed with that of Isnansetyo and Kamei 20013 [16] , in which they used amoxicillin (49 MIC level within 30 min) to permeabilize MSSA cell membranes. SBE is a polar compound that possesses a potential bioactive compound with membrane permeabilizing abilities. The extract, at a minimum concentration of 3.75 mg ml -1 , inhibited growth of MSSA strain ATCC 29247, and at a higher minimum inhibitory concentration, 7.50 mg ml -1 , inhibited MRSA strain ATCC 700698. It was shown to act as a bacterial membrane permeabilizer by showing similar patterns of fluorescence as the positive control antibiotic polymyxin B. Fluorescent intensities of the SBE treated MRSA and MSSA increased exponentially with time until 180 min, considered slow compared to compound MC21-A against MRSA which the intensities increased drastically at 30 min after incubation treatment [16] .
Membrane permeabilization results in loss of membrane potential which promotes leakage. This can be evidenced by fluorescence dye uptakes, similar to kinetics of killing. Even though the role of membrane disruption in determination of the mechanism of action of cationic amphiphilic peptides leading to depolarization, it is not necessarily a lethal event [26] . This study demonstrated the inhibitory activities of anti-MRSA substance from SBE with inhibitory activities on different MRSA strains. It was revealed that anti-MRSA substance from SBE was able to target membrane biosynthesis gene, which in this case was the mprF gene.
Validation of Membrane Disruption Assisting Susceptibility of Conventional Antibiotics
The highest antimicrobial activity was observed from the combination of SBE (2.0 mg/ml) and methicillin (10.0 lg/ ml), which gave a clear zone of 6.0 mm, followed by the combination of SBE (6.0 mg/ml) and ampicillin (10.0 mg/ ml) which showed a clear zone of 5.0 mm, where both combined treatments were against MRSA. No changes in zone sizes were seen for the following antibiotics: gentamicin, 10 lg/ml; oxacillin, 10 lg/ml; penicillin, 10 lg/ml and vancomycin, 30 lg/ml, individually or combined with SBE (Table 1 ). According to FIC index, the combination of SBE-methicillin and SBE-ampicillin showed similar FIC index values of 0.375, indicating synergistic interactions, which agree with findings from modified disc diffusion assay (Table 2) . No indication of antagonism was observed and indifferent relation with the FIC index (value 0.751) was noted between combinations of SBE-penicillin combination.
The ability of any two compounds to work in-combination against pathogens has been hypothesized through the synergistic assay of the checkerboard methods. The synergistic activities recorded between methicillin and SBE showed a similar synergism profile with the combination of ampicillin and SBE. This study illustrated that both ampicillin and SBE can be considered as the most efficient MRSA inhibitor of combined antibacterial agent. MRSA that was resistant to methicillin and ampicillin was well suited for potential enhancement studies of antibacterial agents, revealing beneficial combinations of antibacterial agents. The mechanism by which SBE enhanced the activity of conventional antibiotics has been proposed to involve functional alteration of the bacterial membrane, to the extent that transport mechanisms of L-PG layer were affected, including disruption of membrane permeability itself. Similar work on interaction between antibiotics and non-conventional antibiotics suggested that the mechanism in enhancing the activity of conventional antibiotics The antibacterial activity of SBE incorporated in agar with antibiotic discs determined by the disc diffusion method. The inhibition zones by antibiotic discs against MRSA strains showed that for ampicillin 10 lg discs, the inhibition zones become wider as the concentrations of extract in media increase. While the inhibition zones of methicillin 5 lg were widest at SBE concentration of 2 mg/ml compared to higher concentration. No changes of inhibition zones in other combination of antibacterial agents involved functional alteration of plasma membrane of bacteria [27] . The AMP would act on the outer layer of bacteria, making it easy for conventional antibiotics to penetrate and destroy the pathogens. A mutation studies on mprF gene, the gene responsible for making intact membrane on vancomycin intermediate S. aureus (VISA) isolate, had shown increase in susceptibility to moenomycin, vancomycin and gentamycin [28] . Mutations of mprF gene reduced the L-PG content in the cell membrane, maintained the negative charge and made the membrane vulnerable to positively charged antibiotics. A contradictory finding related to this study showed the presence of mutation affecting the amino acid sequence of mprF in MRSA isolates, in which daptomycin was serially exposed to reduce MRSA susceptibility during therapy. The increase in mutation numbers of mprF gene sequence correlated with elevations in the daptomycin MIC, in which the point of mutations played a role in decreasing susceptibility to daptomycin in the hospital setting [29] . The findings from Friedman (2006) may be specific to daptomycin effects on MRSA and were different from this research findings, which were supported by other studies already discussed.
In conclusion, we identified mprF gene alteration would disturb lysine transport to PG layer, maintained the negatively net charge in MRSA membrane and make it vulnerable to positively charge antimicrobial agent. This finding demonstrated that membrane charge could have an effect on MRSA permeability and susceptibilities to methicillin, ampicillin, penicillin and other conventional antibiotics and CAMPs with positively net charge. The results from this study provided useful information for understanding the application of antibiotic target sites in MRSA, which can assist to find solution on issues of drug resistance in MRSA. 
